Trademarkia Logo

Canada

C$
Trademark Search in Canada
OUTPACE BIO

View On IC.GC.CA

OUTPACE BIO
ADVERTISED

on 24 Jan 2025

Last Applicant/ Owned by

Outpace Bio, Inc.

500 Fairview Ave NSeattle WA 98109

US

Serial Number

2116243 filed on 24th Feb 2021

Registration Number

TMA1285901 registered on 24th Jan 2025

Registration expiry Date

24th Feb 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

CA

V6C2B5

OUTPACE BIO

Trademark usage description

pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and genetic disorders; pharmaceutical preparations and drugs Read More

Classification Information

Class [005]
Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and genetic disorders; pharmaceutical preparations and drugs for the treatment of degenerative diseases, namely, Alzheimer's disease, arthritis, Huntington's disease, Parkinson's disease, and multiple sclerosis; pharmaceutical preparations and drugs for use in regenerative medicine, namely, cartilage and tissue regeneration, platelet-rich plasma, and prolotherapy; Cells for medical or clinical purposes, namely, stem cells for medical purposes, cells for medical laboratory use, and cells for scientific and medical research; proteins for medical or clinical purposes, namely, protein arrays for medical diagnostic purposes; pharmaceutical preparations for use in protein therapy; pharmaceutical preparations for use in cell therapy for medical and clinical purposes; pharmaceutical preparations for use in gene therapy for medical and clinical purposes; kits comprised of cells namely, stem cells, blood cells, leukocytes, and lymphocytes and pharmaceutical preparations all for medical or clinical purposes; kits comprised of proteins, namely, genetically modified cellular proteins and pharmaceutical preparations all for medical or clinical purposes

Classification kind code

11

Class [042]
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, degenerative diseases, regenerative medicine, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy; scientific research and development, namely in the fields of biotechnology, pharmacology, pharmaceuticals, and biochemistry; scientific laboratory services, namely medical laboratory services, biomedical laboratory services, and laboratory services in the fields of biotechnology, pharmacology, pharmaceuticals, and biochemistry; medical and scientific research, namely in the fields of biotechnology, pharmacology, pharmaceuticals, and biochemistry; biotechnology research, synthetic biology research

Classification kind code

11

Class [044]
Medical services, namely in the fields of biotechnology, pharmacology, pharmaceuticals, and biochemistry, and for the treatment of disease

Classification kind code

11

Mark Details

Serial Number

2116243

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 23rd Sept 2022		Agent Changed
Submitted for opposition 22
on 21st Sept 2022		Search Recorded
Submitted for opposition 20
on 21st Sept 2022		Examiner's First Report
Submitted for opposition 223
on 21st Sept 2022		Total Provisional Refusal
Submitted for opposition 256
on 25th Apr 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 24th Jun 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 23rd Jun 2021		Formalized
Submitted for opposition 1
on 23rd Jun 2021		Created
Submitted for opposition 228
on 24th Feb 2021		International Registration
Submitted for opposition 30
on 24th Feb 2021		Filed